DiaMedica (DMAC) Pushes Lower in Pre-Market Trading for June 22

Equities Staff  |

DiaMedica Therapeutics Inc (NASDAQ:DMAC) has already dropped $-0.12 in early trading Wednesday.

After closing the previous trading session at $2.32, DiaMedica has moved 5.17% lower ahead of market open.

The company has risen 2.20% over the last 5 days.

Today could shape up to be an interesting day for DiaMedica investors.

For technical charts, analysis, and more on DiaMedica Therapeutics Inc visit the company profile.

Pre-market prices and movements as of 07:20:44 est.

About DiaMedica Therapeutics Inc

DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing novel treatments to improve the lives of patients with neurological and chronic kidney diseases.

To get more information on DiaMedica Therapeutics Inc and to follow the company's latest updates, you can visit the company's profile page here: DiaMedica Therapeutics Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Trending Articles

The Best Laid Plans of Mice and Men — Part II
Why I’m Buying the 'New' Value Stocks
Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade

Market Movers

Sponsored Financial Content